Available Guidance and Best Practices for Conducting Forced Degradation Studies

Reynolds,Dan;Alsante,Karen;Facchine,Kevin;Mullaney,June;Motto,Michael;Hatajik,Todd;

News

Article

February 1, 2002

Pharmaceutical Technology

Pharmaceutical Technology-02-02-2002

Volume26

Issue 2

Available Guidance and Best Practices for Conducting Forced Degradation Studies

Author(s):

Dan W. Reynolds, PhD,Karen M. Alsante, PhD

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

External Link - article-9668.pdf

Articles in this issue

Using Earned-Value Analysis to Better Manage Projects

Microbial Bioburden on Oral Solid Dosage Forms

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I

Modernizing Pharmaceutical Manufacturing

The Role of Computational Fluid Dynamics in the Pharmaceutical Industry

Available Guidance and Best Practices for Conducting Forced Degradation Studies

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Available Guidance and Best Practices for Conducting Forced Degradation Studies

Newsletter